P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE‐ESCALATION STUDY OF WVT078, A BCMA‐CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA by Raab, M. S., Cohen, Y. C., Schjesvold, F., Aardalen, K., Oka, A., Spencer, A., Wermke, M., Hari, P., Kaufman, J. L., Cafro, A. M., Ocio, E. M., Doki, N., Henson, K., Trabucco, G., Juif, P.‐E., Chawla, R., Cotton, J., Fessehatsion, A., Fan, L., Blankenship, J., Granda, B., Lu, H., De Vita, S.

Get full text

Use of DNA Microarray and Small Animal Positron Emission Tomography in Preclinical Drug Evaluation of RAF265, a Novel B-Raf/VEGFR-2 Inhibitor by Tseng, Jeffrey R, Stuart, Darrin, Aardalen, Kimberly, Kaplan, Angelo, Aziz, Natasha, Hughes, Nicholas P, Gambhir, Sanjiv S

Get full text

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo by TSE, Archie N, RENDAHL, Katherine G, HIBNER, Barbara, GESNER, Thomas G, SCHWARTZ, Gary K, SHEIKH, Tahir, CHEEMA, Haider, AARDALEN, Kim, EMBRY, Millicent, MA, Sylvia, MOLER, Edward J, ZHI JIE NI, LOPES DE MENEZES, Daniel E

Get full text

Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma by Williams, Teresa E, Subramanian, Sharadha, Verhagen, Joelle, McBride, Christopher M, Costales, Abran, Sung, Leonard, Antonios-McCrea, William, McKenna, Maureen, Louie, Alicia K, Ramurthy, Savithri, Levine, Barry, Shafer, Cynthia M, Machajewski, Timothy, Renhowe, Paul A, Appleton, Brent A, Amiri, Payman, Chou, James, Stuart, Darrin, Aardalen, Kimberly, Poon, Daniel

Get full text